LDLR and familial hyperaldosteronism: This genetic defect is mainly due to pathogenic variants of the gene encoding for the LDL receptor (LDLR), which account for more than 90% of genetically confirmed FH cases and result in reduced uptake and clearance of LDL particles which accumulate in the plasma (Nordestgaard et al., 2013).